Skip to content

Airway Segmented Stent Modified With 3D Printing for Malignant Stricture Involving Carina and Distal Bronchi

Covered Metallic Segmented Airway Stent Modified With 3D Printing for Malignant Stricture Involving Carina and Bronchi Distal to Carina: A Multicenter Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03890575
Enrollment
100
Registered
2019-03-26
Start date
2017-04-01
Completion date
2022-12-31
Last updated
2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Neoplasm, Stricture; Trachea

Keywords

3D printed, airway stent, carina, distal bronchi

Brief summary

In this study, we used the covered metallic segmented airway stent to treat malignant strictures involving carina and bronchi distal to carina and aimed to determine the feasibility, efficacy and safety of this technique.

Interventions

The airway stents modified with 3D printing were implanted to treat malignant stricture involving carina and bronchi distal to carina.

Sponsors

Shanghai Pulmonary Hospital, Shanghai, China
CollaboratorOTHER
Shanghai Tong Ren Hospital
CollaboratorOTHER
Ruijin Hospital Luwan Branch
CollaboratorOTHER
Ruijin Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with malignant stricture involving carina and bronchi distal to carina based on the diagnosis by bronchoscopy or CT.

Exclusion criteria

* Severe infection * Coagulation disorders

Design outcomes

Primary

MeasureTime frameDescription
Improvement in Dyspnea using Hugh-Jones classication as criteria3 daysHugh-Jones classication: dyspnea scale that includes 5 categories.
Stent patency time2 monthsStent patency time is defined as the time from the stent implantation to stent restenosis or death due to any cause, or censored at date last known alive.
Overall survival6 monthsOS is defined as the time from the stent implantation to death due to any cause, or censored at date last known alive.

Secondary

MeasureTime frameDescription
Number of participants with adverse events that are related to stent implantation2 monthsAdverse events as follows: migration of the stent, severe chest pain, hemoptysis, granuloma formation, pneumonia and accumulation of secretion

Countries

China

Contacts

Primary ContactZhongmin Wang, MD
wzm0722@hotmail.com0086-13901848333
Backup ContactQungang Shan, MD
qungangshan@sjtu.edu.cn0086-15989037568

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026